Using electronic stimulation, researchers were able to stimulate the recovery of neuron cells grown in a petri dish—a method they hope individuals can use while recovering from traumatic brain injuries (TBIs).

Earlier this month, the FDA approved a contraception app for smartphones that claims to help users prevent pregnancy by monitoring body temperature and menstrual cycles. But critics are questioning the FDA’s move, pointing out that dozens of users got pregnant while using the app.

U.S. aircraft maker Lockheed Martin and Australian software developer ResApp Health are collaborating to develop an app that will tell pilots if they’re fit to fly based on the sound of their cough, according to a report by Business Insider Australia.

When a medical device is recalled, the “why,” in the most general terms, is obvious—something is defective. But new research further examines what goes into recall decisions, finding product managers often rely on physicians to find problems with devices. Additionally, device suppliers can be less likely to issue a recall until the cause of the defect is discovered, which can reduce recall costs.

When compared to an FDA-regulated baby monitor, two smartphone-integrated consumer monitors performed inconsistently and displayed incorrectly low pulse rates, according to a Aug. 21 research letter published in JAMA.

An app designed to help those recovering from breast cancer was recently honored by the National Lottery Awards in the United Kingdom.

Most hospital executives and directors—nearly three in every five—believe Amazon will have the biggest impact in the healthcare market, according to a survey conducted by Reaction Data.

Researchers from Purdue University in West Lafayette, Indiana, is working to develop a new type 1 diabetes therapy that may lead to the long-term reversal of the disease in humans—and man's best friend.